Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities:
Net loss	$ (6,786,037)	$ (5,738,084)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	10,139	23,076
Amortization of intangibles	39,982	34,060
Stock based compensation	1,097,838	499,276
Inventory Reserve	430,245	0
Employees paid in stock	217,262	748,658
Expense paid in stock	436,434	490,614
Bad debt expense	100,000	0
Amortization of right-of-use asset	59,698	59,984
Deferred profit and divesture-equity investment (See Note 6)	0	164,461
Gain on debt extinguishment-PPP	0	(276,180)
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	(248,457)	112,549
(Increase) decrease in inventories	(440,574)	743,647
(Increase) in advances on contracts	(272,223)	(1,095,328)
(Increase) in prepaid expenses and other current assets	(102,858)	(98,501)
Increase in accounts payable	502,292	260,905
Increase in accounts payable, related party	515,142	35,113
(Decrease) increase in accrued expenses	(367,074)	510,790
Decrease in accrued expenses, related party	(80,758)	(51,253)
Decrease operating lease liability	(53,411)	(52,812)
Net cash used in operating activities	(4,942,360)	(3,629,025)
Cash flows from investing activities:
Purchase of furniture, fixtures, and equipment	(3,827)	(19,486)
Net cash used in investing activities	(3,827)	(19,486)
Cash flows from financing activities:
Payments finance lease obligations	(6,486)	(5,779)
Proceeds from exercise of warrants	0	3,150,416
Common stock issued to employee for option exercised	0	770,702
Net cash (used in) provided by financing activities	(6,486)	3,915,339
Net (decrease) increase in cash and cash equivalents	(4,952,673)	266,828
Cash and cash equivalents at beginning of period	14,764,346	14,223,917
Cash and cash equivalents at end of period	$ 9,811,673	$ 14,490,745